Ad is loading...

BIIB Biogen Forecast, Technical & Fundamental Analysis

a manufacturer of therapies for people living with neurological, autoimmune and hematologic disorders

Industry PharmaceuticalsMajor

Get AI intraday signals

BIIB

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For BIIB
(Try 14 days for Free)

View a ticker or compare two or three

Compare

BIIB

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For BIIB
(Try 14 days for Free)

Ad is loading...

A.I. Advisor

published Earnings

BIIB is expected to report earnings to fall 15.44% to $3.45 per share on January 30

Q4'24

Est.

$3.45

Q3'24

Beat

by $0.31

Q2'24

Beat

by $1.27

Q1'24

Beat

by $0.24

Q4'23

Missed

by $0.23

The last earnings report on October 30 showed earnings per share of $4.08, beating the estimate of $3.77. With 780.17K shares outstanding, the current market capitalization sits at 31.34B.

A.I. Advisor

published General Information

General Information

a manufacturer of therapies for people living with neurological, autoimmune and hematologic disorders

Industry PharmaceuticalsMajor

Profile

Fundamentals

Details

Industry

Biotechnology

Address

225 Binney Street

Phone

+1 617 679-2000

Employees

7570

Web

https://www.biogen.com

Interesting Tickers

STOCK / NAME	Price $	Chg $	Chg %
		1 Day
CHGG	1.73	0.05	+2.98%
CHEGG
TEVA	17.03	0.22	+1.31%
Teva Pharmaceutical Industries Limited
FBP	20.69	0.15	+0.73%
First BanCorp
QRTEA	0.36	N/A	-1.23%
Qurate Retail
GNPX	1.10	-0.18	-14.40%
Genprex

BIIB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BIIB has been loosely correlated with AMGN. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if BIIB jumps, then AMGN could also see price increases.

Ticker / NAME	Correlation To BIIB	1D Price Change %
BIIB	100%	+0.37%
AMGN - BIIB	41% Loosely correlated	+2.83%
OGN - BIIB	34% Loosely correlated	+0.96%
NVS - BIIB	31% Poorly correlated	-0.17%
AZN - BIIB	30% Poorly correlated	-0.94%
GILD - BIIB	28% Poorly correlated	+1.00%
More